120 related articles for article (PubMed ID: 11376135)
1. In situ amplification of oestrogen receptor alpha mRNA in breast cancer cell lines and tumours.
Lespagnard L; Gancberg D; Maaroufi Y; Leclercq G; Larsimont D; Verhest A
Mol Pathol; 2001 Jun; 54(3):197-9. PubMed ID: 11376135
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
3. Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction.
Daffada AA; Johnston SR; Nicholls J; Dowsett M
J Mol Endocrinol; 1994 Dec; 13(3):265-73. PubMed ID: 7893344
[TBL] [Abstract][Full Text] [Related]
4. Molecular assay to generate expression profile of eight estrogen receptor alpha isoform mRNA copy numbers in picogram amounts of total RNA from breast cancer tissues.
Poola I
Anal Biochem; 2003 Mar; 314(2):217-26. PubMed ID: 12654308
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of an estrogen receptor messenger RNA containing exon 1' sequences in MCF-7 breast cancer cell line stocks.
Sullivan JA; Spriggs LL; Hill SM
Cancer Lett; 2000 Jan; 148(1):87-93. PubMed ID: 10680597
[TBL] [Abstract][Full Text] [Related]
6. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA
J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414
[TBL] [Abstract][Full Text] [Related]
7. Potential role of p53 on metallothionein induction in human epithelial breast cancer cells.
Fan LZ; Cherian MG
Br J Cancer; 2002 Oct; 87(9):1019-26. PubMed ID: 12434295
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.
Wang HY; Park S; Kim S; Ahn S; Lee D; Kim S; Jung D; Park KH; Lee H
Int J Clin Exp Pathol; 2014; 7(9):5792-800. PubMed ID: 25337220
[TBL] [Abstract][Full Text] [Related]
9. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases.
Leygue E; Hall RE; Dotzlaw H; Watson PH; Murphy LC
Br J Cancer; 1999 Feb; 79(5-6):978-83. PubMed ID: 10070900
[TBL] [Abstract][Full Text] [Related]
11. Variation in use of estrogen receptor-α gene promoters in breast cancer compared by quantification of promoter-specific messenger RNA.
Higuchi T; Gohno T; Nagatomo T; Tokiniwa H; Niwa T; Horiguchi J; Oyama T; Takeyoshi I; Hayashi S
Clin Breast Cancer; 2014 Aug; 14(4):249-57. PubMed ID: 24332559
[TBL] [Abstract][Full Text] [Related]
12. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
Jarzabek K; Koda M; Kozlowski L; Mittre H; Sulkowski S; Kottler ML; Wolczynski S
Eur J Cancer; 2005 Dec; 41(18):2924-34. PubMed ID: 16289616
[TBL] [Abstract][Full Text] [Related]
13. Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.
Tonetti DA; Rubenstein R; DeLeon M; Zhao H; Pappas SG; Bentrem DJ; Chen B; Constantinou A; Craig Jordan V
J Steroid Biochem Mol Biol; 2003 Oct; 87(1):47-55. PubMed ID: 14630090
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients.
Karam M; Bièche I; Legay C; Vacher S; Auclair C; Ricort JM
J Cell Mol Med; 2014 Dec; 18(12):2536-52. PubMed ID: 25287328
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW
Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560
[TBL] [Abstract][Full Text] [Related]
16. Quantification of rainbow trout (Oncorhynchus mykiss) estrogen receptor-alpha messenger RNA and its expression in the ovary during the reproductive cycle.
Nagler JJ; Krisfalusi M; Cyr DG
J Mol Endocrinol; 2000 Oct; 25(2):243-51. PubMed ID: 11013350
[TBL] [Abstract][Full Text] [Related]
17. Molecular assays to profile 10 estrogen receptor beta isoform mRNA copy numbers in ovary, breast, uterus, and bone tissues.
Poola I
Endocrine; 2003 Nov; 22(2):101-12. PubMed ID: 14665713
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor α (ERα) status evaluation using RNAscope in situ hybridization: a reliable and complementary method for IHC in breast cancer tissues.
Yu X; Guo S; Song W; Xiang T; Yang C; Tao K; Zhou L; Cao Y; Liu S
Hum Pathol; 2017 Mar; 61():121-129. PubMed ID: 27993577
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
Endocr Relat Cancer; 2006 Dec; 13(4):1109-20. PubMed ID: 17158757
[TBL] [Abstract][Full Text] [Related]
20. [Alteration of ERalpha expression and tumor invasion by RNA interference against metastasis associated-1 gene in human breast cancer cells].
Jiang QM; Zhang H; Zhang P
Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):118-23. PubMed ID: 18681324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
